Δ-9,11 modification of glucocorticoids dissociates nuclear factor-κ B inhibitory efficacy from glucocorticoid response element-associated side effects

Authors

Andreas R. Baudy, George Washington University
Erica K.M. Reeves, ReveraGen BioPharma, Rockville, MD
Jesse M. Dankser, ReveraGen BioPharma, Rockville, MD
Christopher M. Heier, Children’s National Medical Center, Washington, DC,Follow
Lindsay M. Garvin, George Washington University
Blythe C. Dillingham, ReveraGen BioPharma, Rockville, MD
John McCall, PharMac LLC, Boca Grande, FL
Sree Rayavarapu, George Washington University
Zuyi Wang, George Washington University
Jack H. Vandermeulen, Children’s National Medical Center, Washington, DC
Arpana Sali, Children’s National Medical Center, Washington, DC
Vanessa Jahnke, Children’s National Medical Center, Washington, DC
Stephanie Duguez, Children’s National Medical Center, Washington, DC
Debra DuBois, SUNY at Buffalo
Mary C. Rose, George Washington UniversityFollow
Kanneboyina Nagaraju, George Washington UniversityFollow
Eric P. Hoffman, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

10-2012

Journal

Journal of Pharmacology and Experimental Therapeutics

Volume

Volume 343, Issue 1

Inclusive Pages

225-232

Keywords

Glucocorticoids--adverse effects; Glucocorticoids--pharmacology; NF-kappa B--antagonists & inhibitors; Response Elements--drug effects; Tetrahydrocannabinol--analogs & derivatives

Comments

This is a PubMed Central article. Click on link for full-text access.

APA Citation

Baudy, A. R., Reeves, E. M., Damsker, J. M., Heier, C., Garvin, L. M., Dillingham, B. C., McCall, J., Rayavarapu, S., Wang, Z., Vandermeulen, J.H., Sali, A., Jahnke, V., Duguez, S., DuBois, D., Rose, M.C., Nagaraju, K., Hoffman, E. P. (2012). Δ-9,11 modification of glucocorticoids dissociates nuclear factor-κ B inhibitory efficacy from glucocorticoid response element-associated side effects. The Journal Of Pharmacology And Experimental Therapeutics, 343(1), 225-232.

Peer Reviewed

1

Open Access

1